The VAM agreement between Wu Zhou and major capitals has two revenue thresholds.

They are only the two thresholds of 30 billion and 50 billion.

Who would have thought that in the new fiscal year, most of it will be completed in the first month.

Therefore, the heads of the major capitals are already prepared to lose in this VAM agreement, and they don't even have much hope of winning.

In the case of such a good start, unless Wu Zhou can make a faint move, the performance will decline sharply.

But will Wu Zhou?

In fact, these investors who have established cooperation with Wu Zhou, one is counted as one, and at the beginning of the investment, it is inevitable that there will be some successful enterprise management experience to Wu Zhou after the cooperation is established.

After all, Wu Zhou is still young, and the company is also young, so in their opinion, the Aiying Group, which suddenly jumped up, will definitely have management chaos because the speed of getting up is too fast.

In the process of daily management, Wu Zhou will definitely encounter problems and troubles of one kind or another.

This kind of case abounds, and outsiders look glamorous, but inside they are a mess of dirt.

But the result?

After becoming a shareholder, they watched the speed of Wuzhou's company's crazy expansion, various mergers, internal frictions, integration, and opening, and they watched Wuzhou's employees increase from about 1,000 to 2,000 in just 2 months, and before the lockdown, it exceeded more than 3,000 people.

But with such a rapid rise in speed, Wu Zhou only made some simple personnel adjustments, system changes, and salary changes.

Everything was done in silence, overdone, and so smooth that it felt like a joke.

They have never seen such a smooth process of enterprise mergers and acquisitions in their decades of experience.

It's a bit difficult for such a 'natural entrepreneur' to make him faint frequently.

At the same time, Zhou Lei was in a brainstorming conference call within the company.

A collaborator suddenly asked Zhou Lei.

"Lao Zhou, what are you saying about this Wu Zhou, acquiring a biological R&D company and buying a medical device company?"

After the man finished speaking, the others were silent for a while.

Waiting for Zhou Lei's answer, Zhou Lei and Wu Zhou have always communicated the most.

Judging from the results, Wu Zhou is obviously a risk-taking, far-sighted entrepreneur, in terms of company management, has his own unique forward-looking and innovative thinking, otherwise he would not enter a field, in which industry to stand out, so, why did he enter the medical field, although I have a little guess, but I dare not guarantee. I'll just talk about it. ”

"It may be the existing industry category, Aiying Group has almost reached the ceiling, and it is impossible to have a rapid improvement in performance. Therefore, Wu Zhou has set his sights on the medical field. ”

The size of the global healthcare market is expected to be around $8 trillion, with an average annual growth rate of about 6.7%. In addition, emerging fields such as imaging technology, geometry applications, precision medicine, precision diagnostics and personalized medicine treatment are growing rapidly.

This market is big, very big.

"Entering the healthcare market is challenging. First, they must have a deep understanding of the specificities of the medical industry, and secondly, they need clear goals and strategies and strong operational capabilities in order to stand out from the competition. Otherwise, these investments may end up being possible."

When Zhou Lei heard this, he nodded with a smile.

"It's good to be a success or a failure."

"It has been, from the perspective of national righteousness, we are likely to have a world-class pharmaceutical company in China, which is a good thing for the country and the people. For oneself, this investment will be a return on investment dozens or even hundreds of times. ”

"It doesn't matter if we lose, the VAM agreement between us and Wu Zhou is not only about performance, but also about profit. If Ai Ying Group invests too much in the medical field, resulting in unsatisfactory profits, then the time comes"

After listening to Zhou Lei's words, everyone also laughed.

At present, the top ten pharmaceutical companies in the world, single rice country accounts for more than half.

Pfizer

Johnson

AbbVie

MSD

Bristol-Myers Squibb

These familiar names are all from the United States.

It can be described as an absolute superpower and many powers, and a single United States against the whole world.

However, among these leading enterprises, there is no Huaxia.

As the second largest in the world, no pharmaceutical company can enter the top ten.

I have to say that this is a pity.

Therefore, even at the beginning, he felt that Wu Zhou rashly entered the medical field and was unreliable.

After listening to Zhou Lei's words, I also had some expectations in my heart, what if Wu Zhou can really create another miracle?

But the ideal is still telling him.

"Is it really possible?"

The other side.

"Sinovac, are you kidding?" Normally, Zheng Guoxin would not answer any headhunter calls at all.

It's just that because I've been at home recently, I have relatively more time, and in addition, the current company is not too happy to work.

He has been working in his old employer for more than 13 years, and is currently a director-level researcher, and he is already the absolute backbone of the company, with a salary of more than one million yuan a year. But at this age, he wants to realize value.

Real control. But after doing it for so long, I also found that what really mixes well is related, and a helpless person like him wants to go to the next level, and he doesn't know the year of the monkey.

So, if there is a better opportunity, then of course he is willing to take it.

That's why he's willing to answer headhunter calls.

It's just that after learning that it is a new knowledge, the interest is instantly gone.

The size of the company is far inferior.

The R&D environment is likely to be worse than it is now.

As for the salary?

"Haha, Mr. Zheng, the matter of Kexing is more complicated, and it is not clear in a few words. Let me first tell you about the development plan of the new company and what it can provide you, and you will consider it after listening. ”

Zheng Guoxin hummed softly, but at this moment, the mobile phone had been pressed hands-free and placed on the side of his desk.

"The boss of Sinovac intends to build it into the world's leading biomedical company"

The first sentence of the headhunter's mouth, Zheng Guoxin probably understood that Sinovac was about to change hands, and the new boss should be ready to recruit troops.

It's just that I heard later that I want to become the world's leading biomedical company, this goal is a bit unrealistic, where is it so easy.

Therefore, no matter how bad the impression is at this moment, I feel that the boss of this new company may be even more unreliable than before.

However, the words of the headhunter in the back made him press the finger that was about to hang up the phone and stop slightly.

"In 2020, the company is expected to invest at least 10 billion yuan"

"10 billion, or more?" Zheng Guoxin couldn't help but repeat this number.

It's not to blame him for being surprised, mainly because the contrast is too great.

The company he is currently in is already the current head in China, but the total annual R&D expenses are only 5 billion. And Sinovac, a novice, invested less than a fraction of their company's investment in previous years, and after changing the boss, he was so generous.

Even if he is not very familiar with the domestic capital market, he knows very well that there are not many people with this kind of strength.

Or rather, this headhunter is blowing water.

"I know Director Zheng, you doubt the authenticity of this number, in fact, after learning about this number, I have repeatedly confirmed with the company, and the company's reply is that the boss means that there is only a lot more."

"And like you, the treatment provided by our company is also very good, the signing fee is 500w, and after joining the company, it will lead the group independently, ensuring that the research and development funds of 100 million yuan a year are guaranteed, as for your salary, the basic annual salary is 300w+ project bonus"

As the headhunter said this, he clearly heard a suppressed coughing voice on the other end of the phone.

After he finished speaking, Zheng Guoxin on the other end of the phone was silent for nearly a minute before speaking again.

"Independent grouping, guaranteed 100 million R&D funds, and treatment. It's true? Zheng Guoxin finally had to reconfirm that even in the company now, the most senior dean-level researchers are only a few people, and most of them are only after the project has achieved results, and the additional investment has such a scale.

As for the salary, not to mention, it has far exceeded his current salary.

So I feel a little unreal, and I even feel that I am not deceiving myself.

It's just that I'm just an ordinary R&D person, is it necessary?

"Now that I've said that, I'll get to the bottom of it with Director Zheng. The boss of the new company is surnamed Wu, who is the first good person in our country, and the total amount donated by our total Wu reached 15.7 billion last year. And the enterprise that we Mr. Wu does, either don't do it, or do it to do the best. ”

The headhunter actually said that it is already obvious, even if Zheng Guoxin has a narrow social scope, but during this time, almost all the media channels around him have been bombarded, and the names of Qiao Feijia and Wu Zhou are already familiar.

In fact, his family is also one of the users of Qiao Fei's family.

The snacks that his wife bought for the children were all Qiao Fei's, of course, the snacks were eaten together by the family in the end, and the taste was indeed much better than the others.

In addition, the masks sent by his family to previous member activities have also been worn many times.

From the user's point of view, he has a good impression of Qiao Fei's family and Wu Zhou, the boss.

Although Wu Zhou is a person with no background in the pharmaceutical industry at all, Wu Zhou's company's business products are not compatible with serious medical equipment.

But the last words of the headhunter were right.

It is also the personal experience of their family, and they cannot find a product of the same quality that can be replaced.

The point is that Wu Zhou has also made almost all of the company's products the first place in the entire industry.

If the products of pharmaceutical companies can do the same in the future.

"Can you ask, on the company's side, how many people have similar conditions as me?" Zheng Guoxin asked again.

And listening to Zheng Guoxin's headhunting, a smile also appeared on the corner of his mouth.

He knew that Zheng Guoxin already had an idea in his heart.

However, empathy, unless it is an elm pimple, how can such a favorable condition not be agreed, the foreign market is not clear, but in the domestic and biological industry, this treatment is definitely the top.

Whether it is in terms of treatment or future development, the results are obvious.

"Your treatment is the best on my side. I am in charge of a total of 9 lists, and you are the only one who is treated like this, and the others are worse than you. However, the list provided by Aiying Group is quite large, and all the employees of our company are busy communicating during this time. “

"How many colleagues do you have?"

"More than 200."

(End of chapter)